Free Trial

MultiPlan (MPLN) Stock Forecast & Price Target

$0.45
+0.02 (+4.62%)
(As of 07/23/2024 ET)

MultiPlan - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 1 Wall Street analysts who have issued ratings for MultiPlan in the last 12 months, the stock has a consensus rating of "Hold." Out of the 1 analysts, 1 has given a hold rating for MPLN.

Consensus Price Target

$2.00
341.99% Upside
High Forecast$2.00
Average Forecast$2.00
Low Forecast$2.00

According to the 1 analysts' twelve-month price targets for MultiPlan, the average price target is $2.00. The highest price target for MPLN is $2.00, while the lowest price target for MPLN is $2.00. The average price target represents a forecasted upside of 341.99% from the current price of $0.45.

TypeCurrent Forecast
7/25/23 to 7/24/24
1 Month Ago
6/25/23 to 6/24/24
3 Months Ago
4/26/23 to 4/25/24
1 Year Ago
7/25/22 to 7/25/23
Consensus Rating
Hold
N/AN/A
Hold
Strong Buy
0 Strong Buy rating(s)
N/A N/A
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
N/A N/A
0 Buy rating(s)
Hold
1 Hold rating(s)
N/A N/A
3 Hold rating(s)
Sell
0 Sell rating(s)
N/A N/A
0 Sell rating(s)
Consensus Price Target$2.00$2.00$2.00$1.77
Forecasted Upside341.99% Upside-2.44% Downside-2.44% Downside20.59% Upside
Get MultiPlan Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for MPLN and its competitors with MarketBeat's FREE daily newsletter.

MPLN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MPLN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

MultiPlan Stock vs. The Competition

TypeMultiPlanMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.72
2.51
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside341.99% Upside2,973.35% Upside9.72% Upside
News Sentiment RatingNeutral News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/26/2024Piper Sandler
2 of 5 stars
 Initiated CoverageNeutral$2.00+459.43%
6/30/2023Barclays
2 of 5 stars
 Boost Target$1.00 ➝ $2.00-2.44%
3/8/2023Citigroup
3 of 5 stars
 Lower TargetNeutral$2.00 ➝ $1.25+12.61%
11/16/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$5.50 ➝ $2.05+19.88%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 04:45 AM ET.

MPLN Forecast - Frequently Asked Questions

What is MultiPlan's forecast for 2024?

According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for MultiPlan is $2.00, with a high forecast of $2.00 and a low forecast of $2.00.

Should I buy or sell MultiPlan stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MultiPlan in the last year. There is currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MPLN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MPLN, but not buy additional shares or sell existing shares.

Does MultiPlan's stock price have much upside?

According to analysts, MultiPlan's stock has a predicted upside of 459.44% based on their 12-month stock forecasts.

What analysts cover MultiPlan?

MultiPlan has been rated by research analysts at Piper Sandler in the past 90 days.

Do Wall Street analysts like MultiPlan more than its competitors?

Analysts like MultiPlan less than other "medical" companies. The consensus rating for MultiPlan is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how MPLN compares to other companies.


This page (NYSE:MPLN) was last updated on 7/24/2024 by MarketBeat.com Staff

From Our Partners